Go back

Max IV cash faces legal hurdles

A regional agency in Sweden has written to the government to ask for a change to a law that would prevent it to spread its investment into the Max IV synchrotron radiation facility being built in Lund over several years.

Region Skåne, a state development agency and one of four major financiers of the Max IV laboratory, plans to invest 135 million kronor (€15m) over a number of years in the facility. But this investment is now at risk. According to the newspaper Biotech Idag, Region Skåne plans to account for the money as an investment. But Swedish law only allows such gradual spend by state agencies to be accounted for as an investment when it is spent on state infrastructure such as roads, not large science kit.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.